Skip to main content

Advertisement

Table 2 Phenotypic resistance patterns amongst clinical BHS isolates (n = 186)

From: Incidence of macrolide–lincosamide–streptogramin B resistance amongst beta-haemolytic streptococci in The Gambia

  n (%)
Inducible MLSB 5 (2.7%)
Constitutive MLSB 8 (4.3%)
Macrolide resistance only 2 (1.1%)
Clindamycin resistance only 3 (1.6%)
Macrolide–lincosamide susceptible 168 (90.3%)
Total 186 (100%)
  1. MLS B Macrolide–lincosamide–streptogramin B resistance phenotype